|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
|
EP1303757B1
(en)
|
2000-07-10 |
2006-10-11 |
Vertex Pharmaceuticals (San Diego) LLC |
Ion channel assay methods
|
|
GB0022988D0
(en)
*
|
2000-09-19 |
2000-11-01 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
MXPA04004657A
(es)
|
2001-11-14 |
2004-08-13 |
Teva Pharma |
Formas amorfas y cristalinas de potasio de losartan y proceso para su preparacion.
|
|
AU2005266090A1
(en)
|
2004-07-23 |
2006-02-02 |
Pfizer Inc. |
Pyridine derivatives
|
|
AR063280A1
(es)
|
2006-10-12 |
2009-01-21 |
Xenon Pharmaceuticals Inc |
Uso de compuestos de espiro-oxindol como agentes terapeuticos
|
|
GEP20125379B
(en)
|
2007-05-03 |
2012-01-10 |
Pfizer Ltd |
2 -pyridine carboxamide derivatives as sodium channel modulators
|
|
CA2748251C
(en)
|
2008-12-26 |
2016-08-02 |
Dainippon Sumitomo Pharma Co., Ltd. |
Bicyclic heterocyclic compound for use as a sensory neuron specific sodium channel inhibitor
|
|
CA2760946C
(en)
|
2009-05-07 |
2019-06-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for studying, imaging, and treating pain
|
|
AR077252A1
(es)
|
2009-06-29 |
2011-08-10 |
Xenon Pharmaceuticals Inc |
Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
|
|
WO2011026240A1
(en)
|
2009-09-04 |
2011-03-10 |
Zalicus Pharmaceuticals Ltd. |
Oxopiperazine derivatives for the treatment of pain and epilepsy
|
|
US8598164B2
(en)
|
2010-05-06 |
2013-12-03 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
|
|
MX355907B
(es)
|
2011-02-02 |
2018-05-04 |
Vertex Pharma |
Pirrolopirazina-piperidina espirociclica-amidas como moduladores de canales de ionicos.
|
|
JP5940562B2
(ja)
|
2011-02-18 |
2016-06-29 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
イオンチャネルのモジュレーターとしてのクロマン−スピロ環式ピペリジンアミド
|
|
EP2681200A4
(en)
|
2011-03-03 |
2015-05-27 |
Zalicus Pharmaceuticals Ltd |
INHIBITORS OF BENZIMIDAZOLE TYPE OF SODIUM CHANNEL
|
|
MX347982B
(es)
|
2011-03-14 |
2017-05-22 |
Vertex Pharma |
Morfolina-piperidina espirociclica-amidas como moduladores de canales ionicos.
|
|
EA023375B1
(ru)
|
2011-10-26 |
2016-05-31 |
Пфайзер Лимитед |
Производные (4-фенилимидазол-2-ил)этиламина в качестве модуляторов натриевых каналов
|
|
EP2788332A1
(en)
|
2011-12-07 |
2014-10-15 |
Amgen, Inc. |
Bicyclic aryl and heteroaryl sodium channel inhibitors
|
|
JP6215230B2
(ja)
|
2012-01-16 |
2017-10-18 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
イオンチャネルのモジュレーターとしてのピラン−スピロ環式ピペリジンアミド
|
|
WO2013114250A1
(en)
|
2012-02-03 |
2013-08-08 |
Pfizer Inc. |
Benziimidazole and imidazopyridine derivatives as sodium channel modulators
|
|
WO2013131018A1
(en)
|
2012-03-02 |
2013-09-06 |
Zalicus Pharmaceuticals Ltd. |
Biaryl inhibitors of the sodium channel
|
|
US9051311B2
(en)
|
2012-03-09 |
2015-06-09 |
Amgen Inc. |
Sulfamide sodium channel inhibitors
|
|
US20140211173A1
(en)
|
2013-01-30 |
2014-07-31 |
3M Innovative Properties Company |
Optical projection subsystem
|
|
AU2014212431B2
(en)
|
2013-01-31 |
2018-04-05 |
Vertex Pharmaceuticals Incorporated |
Amides as modulators of sodium channels
|
|
CN105073738B
(zh)
|
2013-01-31 |
2018-01-05 |
沃泰克斯药物股份有限公司 |
作为钠通道调节剂的喹啉及喹喔啉酰胺类
|
|
KR102295748B1
(ko)
|
2013-01-31 |
2021-09-01 |
버텍스 파마슈티칼스 인코포레이티드 |
나트륨 채널의 조절제로서의 피리돈 아미드
|
|
WO2014201173A1
(en)
|
2013-06-12 |
2014-12-18 |
Amgen Inc. |
Bicyclic sulfonamide compounds as sodium channel inhibitors
|
|
ES2654393T3
(es)
|
2013-07-19 |
2018-02-13 |
Vertex Pharmaceuticals Incorporated |
Sulfonamidas como moduladores de los canales de sodio
|
|
LT3080134T
(lt)
|
2013-12-13 |
2018-11-12 |
Vertex Pharmaceuticals Incorporated |
Piridono amidų provaistai, naudotini kaip natrio kanalų moduliatoriai
|
|
EP3129381B1
(en)
|
2014-04-09 |
2020-11-04 |
Siteone Therapeutics Inc. |
10',11'-modified saxitoxins useful for the treatment of pain
|
|
HK1248687B
(en)
|
2015-03-02 |
2020-01-10 |
Amgen Inc. |
Bicyclic ketone sulfonamide compounds
|
|
US10112953B2
(en)
|
2015-09-30 |
2018-10-30 |
Siteone Therapeutics, Inc. |
11,13-modified saxitoxins for the treatment of pain
|
|
US11279706B2
(en)
|
2017-03-29 |
2022-03-22 |
Siteone Therapeutics, Inc. |
11,13-modified saxitoxins for the treatment of pain
|
|
CA3058214A1
(en)
|
2017-03-29 |
2018-10-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
11,13-modified saxitoxins for the treatment of pain
|
|
US11358977B2
(en)
|
2017-05-16 |
2022-06-14 |
Vertex Pharmaceuticals Incorporated |
Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
|
|
SG11202000230VA
(en)
|
2017-07-11 |
2020-02-27 |
Vertex Pharma |
Carboxamides as modulators of sodium channels
|
|
AU2019301628C1
(en)
|
2018-07-09 |
2025-02-06 |
Lieber Institute, Inc. |
Pyridine carboxamide compounds for inhibiting NaV1.8
|
|
AU2019302534B2
(en)
|
2018-07-09 |
2024-10-03 |
Lieber Institute, Inc. |
Pyridazine compounds for inhibiting NaV1.8
|
|
US12162886B2
(en)
|
2018-10-03 |
2024-12-10 |
Siteone Therapeutics, Inc. |
11,13-modified saxitoxins for the treatment of pain
|
|
EP3873893A1
(en)
*
|
2018-11-02 |
2021-09-08 |
Merck Sharp & Dohme Corp. |
2-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitors
|
|
WO2020092187A1
(en)
|
2018-11-02 |
2020-05-07 |
Merck Sharp & Dohme Corp. |
2-amino-n-phenyl-nicotinamides as nav1.8 inhibitors
|
|
EP3891157A4
(en)
|
2018-12-05 |
2022-08-31 |
Merck Sharp & Dohme Corp. |
4-AMINO- OR 4-ALKOXY-SUBSTITUTED ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATE SODIUM CHANNELS
|
|
CA3125244A1
(en)
|
2019-01-04 |
2020-07-09 |
Jiangsu Hengrui Medicine Co., Ltd. |
6-oxo-1,6-dihydropyridazine derivative, preparation method therefor and medical use thereof
|
|
US12441703B2
(en)
|
2019-01-10 |
2025-10-14 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
WO2020146612A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
CN112996774B
(zh)
|
2019-01-25 |
2022-11-22 |
江苏恒瑞医药股份有限公司 |
2-氧代-1,2-二氢吡啶类衍生物、其制备方法及其在医药上的应用
|
|
WO2020261114A1
(en)
|
2019-06-27 |
2020-12-30 |
Glaxosmithkline Intellectual Property Development Limited |
2,3-dihydroquinazolin compounds as nav1.8 inhibitors
|
|
CN112300069A
(zh)
|
2019-07-31 |
2021-02-02 |
明慧医药（上海）有限公司 |
一种选择性钠通道调节剂及其制备和应用
|
|
CN112300051A
(zh)
|
2019-07-31 |
2021-02-02 |
明慧医药（上海）有限公司 |
一种选择性钠通道调节剂及其制备和应用
|
|
WO2021032074A1
(zh)
|
2019-08-19 |
2021-02-25 |
江苏恒瑞医药股份有限公司 |
苯甲酰胺稠芳环类衍生物、其制备方法及其在医药上的应用
|
|
CN112390745B
(zh)
|
2019-08-19 |
2022-10-21 |
江苏恒瑞医药股份有限公司 |
吡啶烟酰胺类衍生物、其制备方法及其在医药上的应用
|
|
CN112441969A
(zh)
|
2019-08-30 |
2021-03-05 |
明慧医药（上海）有限公司 |
一种选择性钠通道调节剂及其制备和应用
|
|
GEP20247688B
(en)
|
2019-09-12 |
2024-11-11 |
Orion Corp |
Pyridine oxynitride, preparation method therefor and use thereof
|
|
CA3164134A1
(en)
|
2019-12-06 |
2021-06-10 |
Vertex Pharmaceuticals Incorporated |
Substituted tetrahydrofurans as modulators of sodium channels
|
|
CN111217776A
(zh)
|
2020-01-19 |
2020-06-02 |
中国人民解放军军事科学院军事医学研究院 |
含苯并杂环结构的酰胺衍生物、组合物和应用
|
|
MX2022015857A
(es)
|
2020-06-10 |
2023-01-24 |
Amgen Inc |
Compuestos de dihidroquinolin sulfonamida de heteroalquilo.
|
|
JP7739051B2
(ja)
|
2020-06-10 |
2025-09-16 |
アムジエン・インコーポレーテツド |
シクロブチルジヒドロキノリンスルホンアミド化合物
|
|
JP2021195367A
(ja)
|
2020-06-10 |
2021-12-27 |
アムジエン・インコーポレーテツド |
シクロプロピルジヒドロキノリンスルホンアミド化合物
|
|
JP2023530319A
(ja)
|
2020-06-17 |
2023-07-14 |
メルク・シャープ・アンド・ドーム・エルエルシー |
Ｎａｖ１．８阻害剤としての２－オキソ－オキサゾリジン－５－カルボキサミド
|
|
GEP20257750B
(en)
|
2020-06-17 |
2025-03-25 |
Merck Sharp & Dohme Llc |
2-oxoimidazolidine-4-carboxamides as nav1.8 inhibitors
|
|
BR112022024476A2
(pt)
|
2020-06-17 |
2022-12-27 |
Merck Sharp & Dohme Llc |
5-oxopirrolidino-3-carboxamidas como inibidores de nav1.8
|
|
JP2023537632A
(ja)
|
2020-08-14 |
2023-09-04 |
サイトワン セラピューティクス インコーポレイテッド |
疼痛の処置のためのＮａＶ１．７の非水和ケトン阻害剤
|
|
WO2022037647A1
(zh)
|
2020-08-19 |
2022-02-24 |
江苏恒瑞医药股份有限公司 |
一种选择性Nav抑制剂的结晶形式及其制备方法
|
|
TW202214259A
(zh)
|
2020-08-19 |
2022-04-16 |
大陸商江蘇恆瑞醫藥股份有限公司 |
一種選擇性ＮａＶ抑制劑的前藥及其晶型
|
|
CN111808019B
(zh)
|
2020-09-08 |
2020-11-27 |
上海济煜医药科技有限公司 |
一种并环化合物及其应用
|
|
CN112225695B
(zh)
|
2020-12-15 |
2021-03-02 |
上海济煜医药科技有限公司 |
一种氮氧化合物及其制备方法和用途
|
|
CN112457294B
(zh)
|
2021-01-27 |
2021-06-04 |
上海济煜医药科技有限公司 |
一种作为NaV1.8阻滞剂的化合物及其制备方法和用途
|
|
CA3221788A1
(en)
*
|
2021-06-04 |
2022-12-08 |
Vertex Pharmaceuticals Incorporated |
Substituted tetrahydrofuran-2-carboxamides as modulators of sodium channels
|